News

News  June Update on Vida Health Program and GLP-1 Coverage

Important Update About GLP-1 medicines (Effective July 1, 2026)
6/08/2026
  • Group Insurance Commission
june 2026 update on vida health program and GLP1 coverage

The Group Insurance Commission (GIC) is making a change to how certain weight loss medicines are covered. This includes medicines like Wegovy, Zepbound, and Saxenda. These are commonly used for weight loss.

Quick Summary

  • Weight loss GLP-1 medicines will not be covered starting July 1, 2026.
  • Some members may still qualify based on medical conditions.
  • Diabetes medicines are not impacted.
  • Vida will continue to offer weight management support, but will no longer prescribe anti-obesity medicines, including GLP-1.
line

What is changing?


Starting July 1, 2026:
  • Medicines used only for weight loss will no longer be covered by your pharmacy benefit.
  • Will GLP-1 medicines still be covered?
    Yes, in some situations.

Coverage may be approved if:
  • You have certain medical conditions, and
  • Your doctor submits a request showing the medicine is being used to treat that condition.

Examples of qualifying conditions include:
  • Heart (cardiovascular) disease
  • Sleep apnea
  • Certain liver conditions (MASH/NASH)


If the medicine is prescribed only for weight loss, it will not be covered.

line

What if I take a GLP-1 medicine for diabetes?


Good news, no change for you.

  • Medicines used for diabetes (like Ozempic or Mounjaro) remain covered.
  • You do not need to enroll in any special program.
  • Coverage will continue as it does today.
line

How is coverage to GLP-1 medicines changing starting July 1, 2026?


Here’s what to expect (if your prescription is for weight loss only):
  • It will not be covered.
  • You will need to pay the full cost out of pocket.

If your prescription is for weight loss plus an FDA qualifying medical condition:

  • Your doctor can request coverage.
  • The request will be reviewed before a decision is made.
line

What is Vida Health, and what do the changes to GLP-1 coverage for obesity mean for me?


Vida is a program that provides:
  • Health coaching
  • Nutrition support
  • Lifestyle guidance
line

Before July 1, 2026:

  • Vida was part of how members accessed weight loss medicines. 

After July 1, 2026:

  • You will no longer be able to schedule visits w/ Vida Physician/Nurse Practitioners.
  • Vida will no longer prescribe anti-obesity medicines,including GLP-1s.
  • Vida will continue to provide weight management support services only.
  • Vida will direct you to your current non-Vida prescriber or, if you don’t have a current physician, the GIC network directory.

This means:

  • Vida cannot approve or prescribe GLP-1 medicines.
  • Medicine coverage decisions are handled through your pharmacy benefit.
  • What if I’m not eligible for the Vida Health program? Some members are not eligible for Vida, including those with:
    • Diabetes
    • Certain complex medical conditions

If this applies to you:

  • You can continue working with your regular doctor regardless of Vida eligibility.
  • Your provider can still request medicine coverage if appropriate.
  • What should I do next if I am or will begin taking a GLP-1 medicine?
line

If you are currently taking a GLP-1 medicine:

  • Step 1: Talk to your PCP or specialist outside of Vida - Ask if your medicine is being used for a condition that may qualify for coverage.
  • Step 2: Confirm your coverage - Your doctor can submit a request if needed.
  • Step 3: Ask questions if you’re unsure.
line

Still have questions?

We understand this is a change and want to make sure you have clear next steps.

  • Group Insurance Commission

    The Group Insurance Commission (GIC) provides high-quality, affordable health insurance and other benefit options to over 220,000 subscribers and 460,000 members.
  • Help Us Improve Mass.gov  with your feedback

    Please do not include personal or contact information.
    Feedback